Your browser doesn't support javascript.
loading
High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi.
Chibwana, Marah G; Jere, Khuzwayo C; Kamn'gona, Raphael; Mandolo, Jonathan; Katunga-Phiri, Vincent; Tembo, Dumizulu; Mitole, Ndaona; Musasa, Samantha; Sichone, Simon; Lakudzala, Agness; Sibale, Lusako; Matambo, Prisca; Kadwala, Innocent; Byrne, Rachel L; Mbewe, Alice; Henrion, Marc Y R; Morton, Ben; Phiri, Chimota; Mallewa, Jane; Mwandumba, Henry C; Adams, Emily R; Gordon, Stephen B; Jambo, Kondwani C.
Afiliação
  • Chibwana MG; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Jere KC; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Kamn'gona R; Centre for Global Vaccine Research, Institute of Infection, Veterinary Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Mandolo J; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Katunga-Phiri V; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Tembo D; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Mitole N; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Musasa S; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Sichone S; Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Lakudzala A; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Sibale L; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Matambo P; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Kadwala I; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Byrne RL; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Mbewe A; Liverpool School of Tropical Medicine, L3 5QA, Liverpool, United Kingdom.
  • Henrion MYR; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Morton B; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Phiri C; Liverpool School of Tropical Medicine, L3 5QA, Liverpool, United Kingdom.
  • Mallewa J; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
  • Mwandumba HC; Liverpool School of Tropical Medicine, L3 5QA, Liverpool, United Kingdom.
  • Adams ER; Ministry of Health, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Gordon SB; Department of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi.
  • Jambo KC; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
medRxiv ; 2020 Aug 05.
Article em En | MEDLINE | ID: mdl-32766597
ABSTRACT

BACKGROUND:

In low-income countries, like Malawi, important public health measures including social distancing or a lockdown have been challenging to implement owing to socioeconomic constraints, leading to predictions that the COVID-19 pandemic would progress rapidly. However, due to limited capacity to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, there are no reliable estimates of the true burden of infection and death. We, therefore, conducted a SARS-CoV-2 serosurvey amongst health care workers (HCWs) in Blantyre city to estimate the cumulative incidence of SARS-CoV-2 infection in urban Malawi.

METHODS:

We recruited 500 otherwise asymptomatic HCWs from Blantyre City (Malawi) from 22nd May 2020 to 19th June 2020 and serum samples were collected from all participants. A commercial ELISA was used to measure SARS-CoV-2 IgG antibodies in serum.

RESULTS:

A total of 84 participants tested positive for SARS-CoV-2 antibodies. The HCWs with positive SARS-CoV-2 antibody results came from different parts of the city. The adjusted seroprevalence of SARS-CoV-2 antibodies was 12.3% [CI 8.2 - 16.5]. Using age-stratified infection fatality estimates reported from elsewhere, we found that at the observed adjusted seroprevalence, the number of predicted deaths was eight times the number of reported deaths.

CONCLUSIONS:

The high seroprevalence of SARS-CoV-2 antibodies among HCWs and the discrepancy in the predicted versus reported deaths suggests that there was early exposure but slow progression of COVID-19 epidemic in urban Malawi. This highlights the urgent need for development of locally parameterised mathematical models to more accurately predict the trajectory of the epidemic in sub-Saharan Africa for better evidence-based policy decisions and public health response planning.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Malauí

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: MedRxiv Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Malauí